In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine

Journal of Pharmaceutical Sciences

Volumn 87, Issue 2, 1998, Pages 226-230

  Desai, Suketu D ^a,b   Blanchard, James ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b Antigenics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ADDITIVE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 4000; METHYLCELLULOSE; PILOCARPINE; POLOXAMER; POLYVINYL ALCOHOL; POVIDONE;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG SOLUBILITY; FLOW KINETICS; GEL; INTRAOCULAR DRUG ADMINISTRATION; SHEAR RATE; SHEAR STRESS; VISCOMETRY; VISCOSITY;

EID: 0031892629     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970090e     Document Type: Article

References (28)

1. Schmolka, I. R. Poloxamers in the Pharmaceutical Industry. In Polymers for Controlled Drug Delivery; Tarcha, P. J., Ed.; CRC Press: Boca Raton, FL, 1991; Chapter 10, pp 189-214.
2. Krezanoski, J. Z. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes. U.S. Patent 4,188,373, 1980.
3. Miyazaki, S.; Nakumura, T.; Yokouchi, C.; Takada, M. Effect of pluronic gels on the rectal absorption of indomethacin in rabbits. Chem. Pharm. Bull. 1987, 35, 1243-1248.
4. Zinner, D. D.; Duany, L. F.; Lutz, H. J. A new desensitizing dentrifice: preliminary report. J. Am. Dent. Assoc. 1977, 95, 982-990.
5. Nalbandian, R. M.; Henry, R. L.; Balko, K. W.; Adams, D. V.; Neuman, N. R. Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs. J. Biomed. Mater. Res. 1987, 21, 1135-1148.
6. Schmolka, I. R. Artificial skin. Preparation and properties of pluronic F-127 gels for the treatment of burns. J. Biomed. Mater. Res. 1972, 6, 571-582.
7. Chen-Chow, P. C.; Frank, S. G. In vitro release of lidocaine from pluronic F-127 gels. Int. J. Pharm. 1981, 8, 88-99.
8. Miyazaki, S.; Takeuchi, S.; Yokouchi, C.; Takada, M. Pluronic F-127 gels as a vehicle for topical administration of anticancer drugs. Chem. Pharm. Bull. 1984, 32, 4205-4208.
9. Tomida, H.; Shinohara, M.; Kuwada, N.; Kiryu, S. In vitro release characteristics of diclofenac and hydrocortisone from Pluronic F127 gels. Acta Pharm. Suec. 1987, 24, 263-272.
10. Guzman, M.; Garcia, F. F.; Molpeceres, J.; Aberturas, M. R. Polyoxyethylene-polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration. Int. J. Pharm. 1992, 80, 119-127.
11. Johnston, T. P.; Punjabi, M. A.; Froelich, C. J. Sustained delivery of Interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm. Res. 1992, 9, 425-434.
12. Miller, S. C.; Donovan, M. D. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int. J. Pharm. 1982, 12, 147-152.
13. Waring, G. O.; Harris, R. R. Double masked evaluation of a poloxamer artificial tear in keratoconjunctivitis. In Symposium on Ocular Therapy; Leopold, J. H., Burns, R. P., Eds.; Wiley: New York, 1979; Vol. 11, pp 127-140.
14. Ford, J. L.; Rubinstein, M. H.; McCaul, F.; Hogan, J. E.; Edgar, P. J. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropyl-methylcellulose matrix tablets. Int. J. Pharm., 1987, 40, 223-234.
15. Urtti, A.; Juslin, M.; Miinalainen, O. Pilocarpine release from hydroxypropyl-cellulose-poly(vinylpyrrolidone) matrixes. Int. J. Pharm. 1985, 25, 165-178.
16. Salminen, L.; Urtti, A.; Kujari, H.; Juslin, M. Prolonged pulse-entry of pilocarpine with a soluble drug insert. Graef's Arch. Clin. Exp. Ophthalmol. 1983, 221, 96-99.
17. Loucas, S. P.; Haddad, H. M. Solid-state ophthalmic dosage systems in effecting prolonged release of pilocarpine in the cul-de-sac. J. Pharm. Sci. 1972, 61, 985-986.
18. Shah, N. B.; Sheth, B. G. A method for study of timed-release films. J. Pharm. Sci. 1972, 61, 412-416.
19. Middleton, D. L.; Leung, S. H.; Robinson, J. R. Ocular bioadhesive delivery systems. In Bioadhesive Drug Delivery System; Lenaerts, V. and Gurny, R., Eds., CRC Press: Boca Raton, FL, 1990; Chapter 10, pp 187-202.
20. Desai, S. D.; Blanchard, J. A simplified and rapid high-performance liquid chromatographic assay for pilocarpine hydrochloride. J. Chromatogr. Sci. 1992, 30, 149-152.
21. Personal communication, Alcon Laboratories, Fort Worth, TX.
22. Nelson, K. G.; Miller, K. W. Principles of Drug Dissolution and Absorption Related to Bioavailability. In Principles and Perspectives in Drug Bioavailability; Blanchard, J., Sawchuk, R. J., Brodie, B. B., Eds.; S. Karger: New York, 1979; pp 20-58.
23. Liesegang, T. J. Viscoelastic substances in ophthalmology. Surv. Ophthalmol. 1990, 34, 268-293.
24. Donbrow, M.; Freidman, M. Enhancement of permeability of ethyl cellulose films for drug penetration. J. Pharm. Pharmacol. 1975, 27, 633-646.
25. Desai, S. D.; Blanchard, J. Ocular Drug Formulation and Delivery. In Encyclopedia of Pharmaceutical Technology; Swarbrick, J., Boylan, J., Eds.; Marcel Dekker: Inc.: New York, 1995; Vol. 11, pp 43-75.
26. Bhardwaj, R.; Blanchard, J. Controlled-release delivery system for the α-MSH analogue Melanotan-I using poloxamer 407. J. Pharm. Sci. 1996, 85, 915-919.
27. Spancake, C. W.; Mitra, A. K.; Kildsig, D. O. Kinetics of aspirin hydrolysis in aqueous solutions and gels of poloxamines (Tetronic 1508) - Influence of microenvironment. Int. J. Pharm. 1991, 75, 231-239.
28. Dumortier, G.; Grossiord, J. L.; Zuber, M.; Couarraze, G.; Chaumeil, J. C. Rheological study of a thermoreversible morphine gel. Drug Dev. Ind. Pharm. 1991, 17, 1255-1265.